NasdaqGM - Delayed Quote USD
XOMA Royalty Corporation (XOMAO)
25.00
-0.15
(-0.60%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-13,748
-13,748
-18,158
-12,879
22,678
Investing Cash Flow
-28,259
-28,259
-711
-20,221
-26,500
Financing Cash Flow
-11,127
-11,127
120,593
-4,451
12,835
End Cash Position
106,416
106,416
159,550
57,826
95,377
Income Tax Paid Supplemental Data
9,985
9,985
--
76
--
Interest Paid Supplemental Data
--
--
--
--
311
Capital Expenditure
-20
-20
-17
-15,247
-26,500
Issuance of Capital Stock
--
--
--
--
40,000
Issuance of Debt
--
--
130,000
--
--
Repayment of Debt
-6,902
-6,902
--
--
-4,250
Repurchase of Capital Stock
-13
-13
--
--
--
Free Cash Flow
-13,768
-13,768
-18,175
-28,126
-3,822
12/31/2021 - 4/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QBIO Q BioMed Inc.
0.0001
0.00%
BYSI BeyondSpring Inc.
1.6900
-5.59%
VCEL Vericel Corporation
38.95
+2.72%
KOD Kodiak Sciences Inc.
4.8000
+6.90%
LCTX Lineage Cell Therapeutics, Inc.
0.4907
-2.64%
TARS Tarsus Pharmaceuticals, Inc.
47.36
-5.84%
GPCR Structure Therapeutics Inc.
27.09
-0.88%
REGN Regeneron Pharmaceuticals, Inc.
605.61
+2.65%
VKTX Viking Therapeutics, Inc.
29.36
+2.60%